{"id":20599,"date":"2026-01-11T18:56:56","date_gmt":"2026-01-11T17:56:56","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=20599"},"modified":"2026-02-17T20:16:25","modified_gmt":"2026-02-17T19:16:25","slug":"how-trump-became-the-unlikely-champion-of-easing-marijuana-restrictions","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2026\/01\/how-trump-became-the-unlikely-champion-of-easing-marijuana-restrictions\/","title":{"rendered":"\u201cHow Trump Became the Unlikely Champion of Easing Marijuana Restrictions”"},"content":{"rendered":"

Opening Statement by National Drug Prevention Alliance – 11 Jan 2026:<\/strong><\/span><\/p>\n

This article, forwarded to NDPA by DWI’s Maggie Petito, is included in NDPA’s website to complete the contemporaneous picture around this extraordinary initiative by President Trump … it is noteworthy that the three main protagonists of this proposal were a CEO of a marijuana company which has donated $750,000 to the (presidential?) inauguration; a police sheriff who has become a supporter of legalising marijuana for recreational use (not just for medicinal use); and a long-term friend of the President in the Mar-a-Lago membership body. It has to be said that this whole episode smells of interest-led lobbying gaining what it wanted, rather than any research-based development of drug policy – this may be an uncharitable conclusion, but time will tell where the truth lies.<\/strong><\/span><\/p>\n

\n

From:<\/strong> drug-watch-international –\u00a0 \u00a0On Behalf Of Maggie Petito –\u00a0 <\/strong>Sent:<\/strong> 28 December 2025\u00a0<\/span>
\nSubject:<\/strong> The Wall Street Journal’sPiece12-28-25<\/span><\/p>\n

Paraphrasing an article by The Wall Street Journal\u2019s Josh Dawsey, in a front-page story (included below)<\/em> Maggie Petito informs on details of how\u00a0 a concerted lobbying push by a cannabis CEO, a Florida sheriff and a Mar-a-Lago member helped persuade the president …<\/span><\/p>\n

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>>>>>>>>>>>>>>><\/span><\/p>\n

After a two-hour Oval Office debate about marijuana in December, President\u00a0Trump\u00a0overrode some on the religious right, White House aides and senior Republican lawmakers and decided to reschedule the green leaf\u00a0as a lower-level drug.<\/span><\/p>\n

Trump watched as\u00a0Kim Rivers, the CEO of Trulieve, a Florida-based marijuana company,\u00a0Gordon Smith, a Florida sheriff, and\u00a0Howard Kessler, a Mar-a-Lago member and longtime Trump friend, argued the president should reschedule marijuana, according to people with knowledge of the meeting\u2026 The decision to reschedule marijuana from a Schedule I drug to a Schedule III drug followed an aggressive 18-month lobbying campaign by Rivers. The CEO and her company cut large checks to Trump\u2019s political groups, attended at least three fundraisers, repeatedly raised the issue with White House aides and hired influential lobbyists.\u00a0Rivers\u2019s efforts delivered the marijuana industry one of its biggest victories. In addition to making medical research easier, the order is expected to eliminate tax burdens that have made profitability an uphill battle for many\u00a0cannabis companies. Cannabis executives say the order will help normalize the business environment for marijuana sellers and improve access for buyers… Rivers first met with Trump on marijuana in summer 2024, when she cut a seven-figure check to a political group helping him, people familiar with the meeting said. Trump then supported a referendum allowing recreational marijuana in Florida\u2026 Rivers hired lobbyists close to Trump, including\u00a0Brian Ballard\u00a0and\u00a0Nick Iarossi. The lobbyists pitched conservatives to write positive op-eds about the marijuana push, among other things, and generate support within the administration. White House officials described Rivers as particularly aggressive in making her case. Trulieve gave another $750,000 to the inauguration. After Trump indicated to Rivers and other donors at a New Jersey fundraiser this summer that he would follow through on rescheduling the drug, industry officials were hopeful. That fundraiser was billed at $1 million a guest\u2026 A follow-up meeting was scheduled, and Rivers asked Gordon Smith, the sheriff of Bradford County\u2014a small county in northern Florida between Jacksonville and Tallahassee\u2014to join her. She also brought two cancer survivors and a Duke University professor. Smith had introduced Trump at a rally about a decade ago and had become one of the first conservative sheriffs to endorse recreational marijuana use.<\/span><\/p>\n

Inside the Oval Office, Trump talked with Kessler, a financial executive who has advocated for medical cannabis, and others about expensive properties in Palm Beach, donations to the White House ballroom and a golf course he wanted to renovate in Washington, Smith recalled. Trump gave opinions on appearances from daughter-in-law\u00a0Lara Trump\u00a0on Fox News and talked about\u00a0Sylvester Stallone\u2019s\u00a0climbing trees and hurting his back\u2026 Trump reviewed polling on rescheduling and said he had heard from many people\u2014including boxer\u00a0Mike Tyson\u2014that he should reschedule. He continually reiterated they were not legalizing it. Smith said Dr.\u00a0Mehmet Oz, who leads Medicaid and Medicare, Health Secretary\u00a0Robert F. Kennedy, and White House chief of staff\u00a0Susie Wiles\u00a0also watched the debate\u2026 Smith\u2019s brother, a military veteran, had been helped by medical marijuana, he said, and he believed it was safer than alcohol and other substances. The sheriff\u2019s concern, he said, was fentanyl-laced marijuana that killed people. When Speaker Johnson called in, the president put him on the phone with the sheriff, who tried to persuade Johnson. `It\u2019s a gateway drug,\u2019 Johnson argued, according to the sheriff. Smith said Johnson was a `nice guy\u2019 and he answered Johnson\u2019s questions. Another person familiar with the meeting said Johnson cited studies and research. Oz argued for rescheduling as Schedule II, Smith and others said.\u00a0 Johnson declined to comment through a spokesman.\u201d<\/span><\/p>\n

\u00a0Again from Dawsey: \u201c\u2026the order is expected to eliminate tax burdens that have made profitability an uphill battle for many cannabis companies. Cannabis executives say the order will help normalize the business environment for marijuana sellers and improve access for buyers.\u201d<\/span><\/p>\n

We do not have a fulsome roster of who or what these largesse-receiving \u201ccompanies\u201d are or do. \u201cNormalizing\u201d differing from \u201clegalizing\u201d loses its distinction when financial access for little known companies or rackets gain tax reductions and financial access, forbidden to similar rackets sometimes called vice or \u201cbusinesses\u201d and crypto\/bitcoin\u2019s opaque\/unaccountable systems seeking false junctures with sound monetary structures. We do not know whose polling was applied. I do not check Trulieve\u2019s financial statements.<\/span><\/p>\n

THE WALL STREET JOURNAL ARTICLE:\u00a0 by <\/strong>Josh Dawsey\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dec. 27, 2025<\/strong><\/span><\/p>\n

How Trump Became the Unlikely Champion of Easing Marijuana Restrictions –\u00a0<\/strong>Concerted lobbying push by a cannabis CEO, a Florida sheriff and a Mar-a-Lago member helped persuade the president<\/strong><\/span><\/p>\n

The president agreed to make marijuana a Schedule III drug.\u00a0Evan Vucci\/AP<\/span><\/p>\n

President Trump decided to reschedule marijuana as a lower-level drug after an Oval Office debate, overriding some Republicans and religious right figures.<\/span><\/p>\n

After a two-hour Oval Office debate about marijuana in December, President\u00a0Trump\u00a0overrode some on the religious right, White House aides and senior Republican lawmakers and decided to reschedule the green leaf\u00a0as a lower-level drug.<\/span><\/p>\n

Trump watched as\u00a0Kim Rivers, the CEO of Trulieve, a Florida-based marijuana company,\u00a0Gordon Smith, a Florida sheriff, and\u00a0Howard Kessler, a Mar-a-Lago member and longtime Trump friend, argued the president should reschedule marijuana, according to people with knowledge of the meeting. It was time to open the door for medical research and improve access to cannabidiol products, they argued.<\/span><\/p>\n

House Speaker\u00a0Mike Johnson\u00a0(R., La.) on speakerphone urged the president against the decision and senior aides warned the move could be dangerous to some Americans.<\/span><\/p>\n

After listening, Trump, a teetotaler who eschews alcohol and drugs, sided with the pro-marijuana camp and delivered the biggest softening of federal cannabis policy since U.S. states began legalizing recreational marijuana in 2012.<\/span><\/p>\n

\u201cIt was a little surreal,\u201d Rivers said in an interview.\u00a0<\/span><\/p>\n

The decision to reschedule marijuana from a Schedule I drug to a Schedule III drug followed an aggressive 18-month lobbying campaign by Rivers. The CEO and her company cut large checks to Trump\u2019s political groups, attended at least three fundraisers, repeatedly raised the issue with White House aides and hired influential lobbyists.\u00a0<\/span><\/p>\n

Rivers\u2019s efforts delivered the marijuana industry one of its biggest victories. In addition to making medical research easier, the order is expected to eliminate tax burdens that have made profitability an uphill battle for many\u00a0cannabis companies. Cannabis executives say the order will help normalize the business environment for marijuana sellers and improve access for buyers.<\/span><\/p>\n

\u201cThe president heard from many different people on this issue and ultimately felt it was the best policy and political decision to make for the country. On all issues, the president is the final decision maker,\u201d said White House press secretary\u00a0Karoline Leavitt.<\/span><\/p>\n

Conservative and religious leaders, such as the Faith and Freedom Coalition\u2019s\u00a0Ralph Reed, had asked the White House not to reclassify the drug, saying it could be a gateway to other drugs and didn\u2019t fit with the president\u2019s agenda. Reed and allies argued medical studies had not shown health or medicinal benefits. Heidi Overton, a top aide on the conservative domestic policy council, repeatedly weighed in against it, including in the meeting where Trump made the decision, people with knowledge of the meeting said. Through a spokeswoman, she declined to comment.<\/span><\/p>\n

Some White House officials, including deputy chief of staff James Blair, told Trump that many Republicans were opposed, and aides showed him a letter signed by 22 senators urging against it, White House officials said.<\/span><\/p>\n

\u201cThe only winners from rescheduling will be bad actors such as Communist China, while Americans will be left paying the bill,\u201d the senators wrote.<\/span><\/p>\n

Leavitt, the White House spokeswoman, said that \u201cit\u2019s Blair\u2019s job to convey to the president what the Hill thinks, and what the politics are, on every issue.\u201d<\/span><\/p>\n

For many months, the policy seemed on hold. Rivers first met with Trump on marijuana in summer 2024, when she cut a seven-figure check to a political group helping him, people familiar with the meeting said. Trump then supported a referendum allowing recreational marijuana in Florida. Trump also said on the campaign trail that he would reschedule the drug, but it wasn\u2019t in his first slate of executive orders. Some in the industry grew frustrated, believing Trump\u2019s staff was stalling.\u00a0<\/span><\/p>\n

Rivers hired lobbyists close to Trump, including\u00a0Brian Ballard\u00a0and\u00a0Nick Iarossi. The lobbyists pitched conservatives to write positive op-eds about the marijuana push, among other things, and generate support within the administration. White House officials described Rivers as particularly aggressive in making her case. Trulieve gave another $750,000 to the inauguration.<\/span><\/p>\n

After Trump indicated to Rivers and other donors at a New Jersey fundraiser this summer that he would follow through on rescheduling the drug, industry officials were hopeful. That fundraiser was billed at $1 million a guest. Behind the scenes, White House officials expressed frustration, people familiar with the matter said, and Trump waffled when publicly asked about rescheduling days later.<\/span><\/p>\n

Rivers didn\u2019t give up, and again came to a golf fundraiser for Sen.\u00a0Lindsey Graham\u00a0(R., S.C.) in November. She and Trump spoke briefly, and she asked for a White House meeting.<\/span><\/p>\n

\u201cWhen I\u2019m there, it\u2019s a natural conversation topic\u2014he asks me about business and how things are going,\u201d Rivers said of the fundraiser. \u201cThe president has been very consistent on this issue.\u201d<\/span><\/p>\n

Rivers\u2019s efforts appeared to be bearing fruit when Trump invited her to the Oval Office to make her case. She was met in the Oval by Overton, who disagreed, and Trump didn\u2019t make a final decision.<\/span><\/p>\n

A follow-up meeting was scheduled, and Rivers asked Gordon Smith, the sheriff of Bradford County\u2014a small county in northern Florida between Jacksonville and Tallahassee\u2014to join her. She also brought two cancer survivors and a Duke University professor. Smith had introduced Trump at a rally about a decade ago and had become one of the first conservative sheriffs to endorse recreational marijuana use.<\/span><\/p>\n

Inside the Oval Office, Trump talked with Kessler, a financial executive who has advocated for medical cannabis, and others about expensive properties in Palm Beach, donations to the White House ballroom and a golf course he wanted to renovate in Washington, Smith recalled. Trump gave opinions on appearances from daughter-in-law\u00a0Lara Trump\u00a0on Fox News and talked about\u00a0Sylvester Stallone\u2019s\u00a0climbing trees and hurting his back.<\/span><\/p>\n

Trulieve CEO Kim Rivers triumphed despite objections from some of those close to the president.\u00a0Douglas R. Clifford\/Zuma Press<\/span><\/p>\n

\u201cSome of the conversation was way above my pay grade,\u201d Smith said.\u00a0Kessler didn\u2019t respond to requests for comment.\u00a0<\/span><\/p>\n

Trump reviewed polling on rescheduling and said he had heard from many people\u2014including boxer\u00a0Mike Tyson\u2014that he should reschedule. He continually reiterated they were not legalizing it. Smith said Dr.\u00a0Mehmet Oz, who leads Medicaid and Medicare, Health Secretary\u00a0Robert F. Kennedy, and White House chief of staff\u00a0Susie Wiles\u00a0also watched the debate. Wiles left early. At one point, Trump zeroed in on Smith.<\/span><\/p>\n

\u201cHe turned to me and said, \u2018Sheriff, what do you think?\u2019 \u201d Smith\u2019s brother, a military veteran, had been helped by medical marijuana, he said, and he believed it was safer than alcohol and other substances. The sheriff\u2019s concern, he said, was fentanyl-laced marijuana that killed people.<\/span><\/p>\n

When Speaker Johnson called in, the president put him on the phone with the sheriff, who tried to persuade Johnson. \u201cIt\u2019s a gateway drug,\u201d Johnson argued, according to the sheriff. Smith said Johnson was a \u201cnice guy\u201d and he answered Johnson\u2019s questions. Another person familiar with the meeting said Johnson cited studies and research. Oz argued for rescheduling as Schedule II, Smith and others said.\u00a0 Johnson declined to comment through a spokesman.\u00a0<\/span><\/p>\n

The president said Democrats should have rescheduled the drug \u201cbecause it was really a Democratic issue.\u201d The Biden administration started the process of reclassifying pot last year, but didn\u2019t finish. After about two hours, Trump said he was going to reschedule the drug and said he wanted to post on Truth Social, the sheriff recalled. Trump said he wanted everyone on board.<\/span><\/p>\n

\u201cThe lawyers and his staff, they started yelling, \u2018No sir, you can\u2019t yet; there\u2019s a 30-day period, it\u2019s gotta go through this and that,\u2019 \u201d Smith said. \u201cThey had to stop him from posting.\u201d<\/span><\/p>\n

Trump then instructed the sheriff and staffers to go into another room and put together an executive order. Trump wanted to put the \u201creal story of why we are doing this in the order,\u201d Smith said.<\/span><\/p>\n

\u201cI was in awe of the whole thing,\u201d he said.<\/span><\/p>\n

Trump invited Smith to come back the next week and see him sign the order, but Smith said he couldn\u2019t\u2014he had to attend an execution in Florida that evening. Trump told others that Rivers had pushed him to do it, said people familiar with the matter.<\/span><\/p>\n

Announcing the order from the White House podium on Dec. 18, Trump thanked Kessler, saying, \u201cWe have people begging for me to do this, people that are in great pain. I have probably received more phone calls on this, on doing what we\u2019re doing.\u201d<\/span><\/p>\n

Source:\u00a0www.drugwatch.org<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Opening Statement by National Drug Prevention Alliance – 11 Jan 2026: This article, forwarded to NDPA by DWI’s Maggie Petito, is included in NDPA’s website to complete the contemporaneous picture around this extraordinary initiative by President Trump … it is noteworthy that the three main protagonists of this proposal were a CEO of a marijuana […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30,32,129,68,136,60,119,40,36,19,61],"tags":[],"class_list":["post-20599","post","type-post","status-publish","format-standard","hentry","category-cannabis-marijuana","category-crime-violence-prison","category-culture","category-drug-use-various-effects","category-hemp","category-marijuana-and-medicine","category-prevalence","category-prevention-research","category-treatment-addiction","category-usa","category-youth"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/20599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=20599"}],"version-history":[{"count":2,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/20599\/revisions"}],"predecessor-version":[{"id":20601,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/20599\/revisions\/20601"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=20599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=20599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=20599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}